The direct effect of estrogen on cell viability and apoptosis in human gastric cancer cells

Molecular and Cellular Biochemistry

Volumn 395, Issue 1-2, 2014, Pages 99-107

  Qin, Jian ^a   Liu, Min ^a   Ding, Qianshan ^c   Ji, Xiang ^c   Hao, Yarong ^a   Wu, Xiaomin ^b   Xiong, Jie ^c  

^a RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

^b Wuhan Centers for Disease Prevention and Control   (China)

^c WUHAN UNIVERSITY   (China)

Author keywords

Apoptosis; Estrogen; Estrogen receptor; Gender disparity; PEG10

Indexed keywords

CASPASE 3; ESTRADIOL; ESTROGEN; PROTEIN BCL 2; PROTEIN BCL XL; BCL2L1 PROTEIN, HUMAN; CASP3 PROTEIN, HUMAN; ESTROGEN RECEPTOR; PROTEIN BCL X;

APOPTOSIS; ARTICLE; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; ENZYME ACTIVATION; FLOW CYTOMETRY; GASTRIC CANCER CELL LINE; GENE EXPRESSION; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; SURVIVAL RATE; DRUG EFFECTS; GENE EXPRESSION REGULATION; MALE; METABOLISM; PATHOLOGY; STOMACH TUMOR; TUMOR CELL LINE;

APOPTOSIS; BCL-X PROTEIN; CASPASE 3; CELL LINE, TUMOR; CELL SURVIVAL; ESTRADIOL; ESTROGENS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; RECEPTORS, ESTROGEN; STOMACH NEOPLASMS;

EID: 84906316121     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-014-2115-2     Document Type: Article

References (35)

1. Bertuccio P, Chatenoud L, Levi F, Praud D, Ferlay J, Negri E, Malvezzi M, La Vecchia C (2009) Recent patterns in gastric cancer: a global overview. Int J Cancer 125(3):666-673. doi:10.1002/ijc.24290
2. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61(2):69-90
3. Sipponen P, Correa P (2002) Delayed rise in incidence of gastric cancer in females results in unique sex ratio (M/F) pattern: etiologic hypothesis. Gastric Cancer 5(4):213-219. doi:10.1007/s101200200037 (Pubitemid 36605884)
4. Chandanos E, Lagergren J (2008) Oestrogen and the enigmatic male predominance of gastric cancer. Eur J Cancer 44(16):2397-2403. doi:10.1016/j.ejca.2008.07.031
5. Lindblad M, Ye W, Rubio C, Lagergren J (2004) Estrogen and risk of gastric cancer: a protective effect in a nationwide cohort study of patients with prostate cancer in Sweden. Cancer Epidemiol Biomarkers Prev 13(12):2203-2207 (Pubitemid 40054318)
6. Ohtani M, Garcia A, Rogers AB, Ge Z, Taylor NS, Xu S, Watanabe K, Marini RP, Whary MT, Wang TC, Fox JG (2007) Protective role of 17 beta -estradiol against the development of Helicobacter pylori-induced gastric cancer in INS-GAS mice. Carcinogenesis 28(12):2597-2604. doi:10.1093/carcin/bgm150 (Pubitemid 350238963)
7. Ohtani M, Ge Z, Garcia A, Rogers AB, Muthupalani S, Taylor NS, Xu S, Watanabe K, Feng Y, Marini RP, Whary MT, Wang TC, Fox JG (2011) 17 beta-estradiol suppresses Helicobacter pylori-induced gastric pathology in male hypergastrinemic INSGAS mice. Carcinogenesis 32(8):1244-1250. doi:10.1093/carcin/bgr072
8. El-Serag HB, Rudolph KL (2007) Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 132(7):2557-2576. doi:10.1053/j.gastro.2007.04.061 (Pubitemid 46890874)
9. Bosch FX, Ribes J, Diaz M, Cleries R (2004) Primary liver cancer: worldwide incidence and trends. Gastroenterology 127(5 Suppl 1):S5-S16 (Pubitemid 39423365)
10. Ma WL, Hsu CL, Wu MH, Wu CT, Wu CC, Lai JJ, Jou YS, Chen CW, Yeh S, Chang C (2008) Androgen receptor is a new potential therapeutic target for the treatment of hepatocellular carcinoma. Gastroenterology 135(3):947-955. doi:10.1053/j.gastro.2008.05.046 955 e941-945
11. Ryu WS, Kim JH, Jang YJ, Park SS, Um JW, Park SH, Kim SJ, Mok YJ, Kim CS (2012) Expression of estrogen receptors in gastric cancer and their clinical significance. J Surg Oncol 106(4):456-461. doi:10.1002/jso.23097
12. Takano N, Iizuka N, Hazama S, Yoshino S, Tangoku A, Oka M (2002) Expression of estrogen receptor-alpha and -beta mRNAs in human gastric cancer. Cancer Lett 176(2):129-135 (Pubitemid 34136011)
13. Wang M, Pan JY, Song GR, Chen HB, An LJ, Qu SX (2007) Altered expression of estrogen receptor alpha and beta in advanced gastric adenocarcinoma: correlation with prothymosin alpha and clinicopathological parameters. Eur J Surg Oncol 33(2):195-201. doi:10.1016/j.ejso.2006.09.009 (Pubitemid 46336548)
14. Xu CY, Guo JL, Jiang ZN, Xie SD, Shen JG, Shen JY, Wang LB (2010) Prognostic role of estrogen receptor alpha and estrogen receptor beta in gastric cancer. Ann Surg Oncol 17(9):2503-2509. doi:10.1245/s10434-010-1031-2
15. Feng H, Cheng AS, Tsang DP, Li MS, Go MY, Cheung YS, Zhao GJ, Ng SS, Lin MC, Yu J, Lai PB, To KF, Sung JJ (2011) Cell cycle-related kinase is a direct androgen receptor-regulated gene that drives beta-catenin/T cell factor-dependent hepatocarcinogenesis. J Clin Investig 121(8):3159-3175. doi:10.1172/JCI45967
16. Okabe H, Satoh S, Kato T, Kitahara O, Yanagawa R, Yamaoka Y, Tsunoda T, Furukawa Y, Nakamura Y (2001) Genome-wide analysis of gene expression in human hepatocellular carcinomas using cDNA microarray: identification of genes involved in viral carcinogenesis and tumor progression. Cancer Res 61(5):2129-2137 (Pubitemid 32692038)
17. Tsou AP, Chuang YC, Su JY, Yang CW, Liao YL, Liu WK, Chiu JH, Chou CK (2003) Overexpression of a novel imprinted gene, PEG10, in human hepatocellular carcinoma and in regenerating mouse livers. J Biomed Sci 10(6 Pt 1):625-635
18. Okabe H, Satoh S, Furukawa Y, Kato T, Hasegawa S, Nakajima Y, Yamaoka Y, Nakamura Y (2003) Involvement of PEG10 in human hepatocellular carcinogenesis through interaction with SIAH1. Cancer Res 63(12):3043-3048 (Pubitemid 36735848)
19. Chunsong H, Yuling H, Li W, Jie X, Gang Z, Qiuping Z, Qingping G, Kejian Z, Li Q, Chang AE, Youxin J, Jinquan T (2006) CXC chemokine ligand 13 and CC chemokine ligand 19 cooperatively render resistance to apoptosis in B cell lineage acute and chronic lymphocytic leukemia CD23+ CD5+ B cells. J Immunol 177(10):6713-6722 (Pubitemid 44715035)
20. Xiong J, Qin J, Zheng Y, Peng X, Luo Y, Meng X (2012) PEG10 promotes the migration of human Burkitt's lymphoma cells by up-regulating the expression of matrix metalloproteinase-2 and -9. Clin Invest Med 35(3):E117-E125
21. O'Neill PA, Davies MP, Shaaban AM, Innes H, Torevell A, Sibson DR, Foster CS (2004) Wild-type oestrogen receptor beta (ERbeta1) mRNA and protein expression in Tamoxifen-treated post-menopausal breast cancers. Br J Cancer 91(9):1694-1702 (Pubitemid 39546143)
22. Morgan M, Kniss D, McDonnell S (1998) Expression of metalloproteinases and their inhibitors in human trophoblast continuous cell lines. Exp Cell Res 242(1):18-26 (Pubitemid 28366516)
23. Nelson AR, Fingleton B, Rothenberg ML, Matrisian LM (2000) Matrix metalloproteinases: biologic activity and clinical implications. J Clin Oncol 18(5):1135-1149 (Pubitemid 30123793)
24. Kalaitzidis D, Gilmore TD (2005) Transcription factor cross-talk: the estrogen receptor and NF-kappaB. Trends Endocrinol Metab 16(2):46-52 (Pubitemid 40270849)
25. Hayden MS, Ghosh S (2004) Signaling to NF-kappaB. Genes Dev 18(18):2195-2224
26. Dai Y, Chen S, Wang L, Pei XY, Funk VL, Kramer LB, Dent P, Grant S (2011) Disruption of IkappaB kinase (IKK)-mediated RelA serine 536 phosphorylation sensitizes human multiple myeloma cells to histone deacetylase (HDAC) inhibitors. J Biol Chem 286(39):34036-34050
27. Brekman A, Singh KE, Polotskaia A, Kundu N, Bargonetti J (2011) A p53-independent role of Mdm2 in estrogen-mediated activation of breast cancer cell proliferation. Breast Cancer Res 13(1):R3
28. Chaudhri RA, Olivares-Navarrete R, Cuenca N, Hadadi A, Boyan BD, Schwartz Z (2012) Membrane estrogen signaling enhances tumorigenesis and metastatic potential of breast cancer cells via estrogen receptor-alpha36 (ERalpha36). J Biol Chem 287(10):7169-7181. doi:10.1074/jbc.M111.292946
29. Roy R, Moses MA (2012) ADAM12 induces estrogen-independence in breast cancer cells. Breast Cancer Res Treat 131(3):731-741. doi:10.1007/s10549-011- 1431-4
30. Moore RL, Faller DV (2013) SIRT1 represses estrogen-signaling, ligand-independent ERalpha-mediated transcription, and cell proliferation in estrogen-responsive breast cells. J Endocrinol 216(3):273-285
31. Elmore S (2007) Apoptosis: a review of programmed cell death. Toxicol Pathol 35(4):495-516. doi:10.1080/01926230701320337
32. Catz SD, Johnson JL (2001) Transcriptional regulation of bcl-2 by nuclear factor kappa B and its significance in prostate cancer. Oncogene 20(50):7342-7351. doi:10.1038/sj.onc.1204926 (Pubitemid 33078205)
33. Cheng JC, Chou CH, Kuo ML, Hsieh CY (2006) Radiation-enhanced hepatocellular carcinoma cell invasion with MMP-9 expression through PI3K/Akt/NF-kappaB signal transduction pathway. Oncogene 25(53):7009-7018. doi:10.1038/sj.onc.1209706 (Pubitemid 44722069)
34. Zhou J, Teng R, Xu C, Wang Q, Guo J, Xu C, Li Z, Xie S, Shen J, Wang L (2013) Overexpression of ER alpha inhibits proliferation and invasion of MKN28 gastric cancer cells by suppressing betacatenin. Oncol Rep 30(4):1622-1630. doi:10.3892/or.2013.2610
35. Xu H, Wei Y, Zhang Y, Xu Y, Li F, Liu J, Zhang W, Han X, Tan R, Shen P (2012) Oestrogen attenuates tumour progression in hepatocellular carcinoma. J Pathol 228(2):216-229. doi:10.1002/path.4009